Gilead's antibiotic Cayston denied EU marketing endorsement
23 March 2009
Katie McQue
Please Login to read the full article.
23 March 2009
Katie McQue
katie.mcque@informa.com
The EU's
CHMP has adopted a negative opinion of
Gilead's inhaled antibiotic Cayston (aztreonam lysine) for the treatment of chronic airway infections caused by
Pseudomonas aeruginosa in adults with cystic fibrosis because the committee was not convinced that the drug's benefits outweighed...
Please Login to read the full article.
RELATED CONTENT
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
